| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Frederikke Jeppesen Kragh, Marie Bruun, Esben Budtz-Jørgensen, Lena Elisabeth Hjermind, Robin Schubert, Ralf Reilmann, Jørgen Erik Nielsen, Steen Gregers Hasselbalc. Quantitative Measurements of Motor Function in Alzheimer's Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study. Dementia and geriatric cognitive disorders. vol 46. issue 3-4. 2019-01-28. PMID:30257254. |
this study examines the efficacy of using quantitative measurements of motor dysfunction, compared to clinical ratings, in alzheimer's disease (ad), frontotemporal dementia (ftd), and dementia with lewy bodies (dlb). |
2019-01-28 |
2023-08-13 |
Not clear |
| Gabriel Santpere, Paula Garcia-Esparcia, Pol Andres-Benito, Belen Lorente-Galdos, Arcadi Navarro, Isidro Ferre. Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies. Brain pathology (Zurich, Switzerland). vol 28. issue 3. 2019-01-24. PMID:28321951. |
the present study investigates global transcriptional changes in frontal cortex area 8 in incidental lewy body disease (ilbd), parkinson disease (pd) and dementia with lewy bodies (dlb). |
2019-01-24 |
2023-08-13 |
Not clear |
| Gabriel Santpere, Paula Garcia-Esparcia, Pol Andres-Benito, Belen Lorente-Galdos, Arcadi Navarro, Isidro Ferre. Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies. Brain pathology (Zurich, Switzerland). vol 28. issue 3. 2019-01-24. PMID:28321951. |
our findings provide, for the first time, evidence of molecular cortical alterations in ilbd and involvement of several key metabolic pathways and gene hubs in dlb which may underlie cognitive impairment and dementia. |
2019-01-24 |
2023-08-13 |
Not clear |
| Olivier Bousiges, Frédéric Blan. Diagnostic value of cerebrospinal fluid alpha-synuclein in dementia with Lewy body. Geriatrie et psychologie neuropsychiatrie du vieillissement. vol 16. issue 3. 2019-01-22. PMID:30168437. |
dementia with lewy body (dlb) is the second most common form of dementia after alzheimer's disease (ad), accounting for 15% to 20% of neuropathologically defined cases. |
2019-01-22 |
2023-08-13 |
human |
| Diana Duro, Miguel Tábuas-Pereira, Sandra Freitas, Beatriz Santiago, Maria Amália Botelho, Isabel Santan. Validity and Clinical Utility of Different Clock Drawing Test Scoring Systems in Multiple Forms of Dementia. Journal of geriatric psychiatry and neurology. vol 31. issue 3. 2019-01-09. PMID:29742972. |
we selected patients with a clinical diagnosis of mild stage ad, behavioral variant frontotemporal dementia (ftd), vascular dementia (vad), dementia with lewy bodies (dlb), and parkinson disease with dementia (pdd). |
2019-01-09 |
2023-08-13 |
Not clear |
| Shuta Toru, Tadashi Kanouchi, Takanori Yokota, Yosuke Yagi, Akira Machida, Takayoshi Kobayash. Utility of Autonomic Function Tests to Differentiate Dementia with Lewy Bodies and Parkinson Disease with Dementia from Alzheimer Disease. European neurology. vol 79. issue 1-2. 2019-01-07. PMID:29131019. |
we studied autonomic disturbance in patients with dementia with lewy bodies (dlb), parkinson disease with dementia (pdd), alzheimer disease (ad), to determine whether autonomic function tests can be used to distinguish these disorders. |
2019-01-07 |
2023-08-13 |
Not clear |
| Fang Fang, Wanlin Yang, Jazmin B Florio, Edward Rockenstein, Brian Spencer, Xavier M Orain, Stephanie X Dong, Huayan Li, Xuqiao Chen, Kijung Sung, Robert A Rissman, Eliezer Masliah, Jianqing Ding, Chengbiao W. Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease. Scientific reports. vol 7. issue 1. 2018-12-31. PMID:28634349. |
recent studies have demonstrated that hyperphosphorylation of tau protein plays a role in neuronal toxicities of α-synuclein (asyn) in neurodegenerative disease such as familial alzheimer's disease (ad), dementia with lewy bodies (dlb) and parkinson's disease. |
2018-12-31 |
2023-08-13 |
mouse |
| Mehrshad Abbasi, Nafise Ghalandari, Saeed Farzanefar, Vajiheh Aghamollaii, Mona Ahmadi, Morsaleh Ganji, Mohsen Afarideh, Sogol Loloee, Maryam Naseri, Abbas Tafakhor. Potential diagnostic value of Clinical neurology and neurosurgery. vol 163. 2018-12-19. PMID:29112909. |
potential diagnostic value of clinical difficulty to discriminate between the alzheimer disease (ad) and dementia with lewy bodies (dlb) has led researchers to focus on highly sensitive functional imaging modalities. |
2018-12-19 |
2023-08-13 |
Not clear |
| Katelyn Becker, Xinhe Wang, Kayla Vander Stel, Yaping Chu, Jeffrey Kordower, Jiyan M. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA. Molecular neurobiology. vol 55. issue 11. 2018-12-17. PMID:29589283. |
alpha synuclein (α-syn) is central to the pathogenesis of a group of neurodegenerative disorders known as synucleinopathies, including parkinson's disease (pd), dementia with lewy bodies (dlb), and multiple system atrophy (msa). |
2018-12-17 |
2023-08-13 |
Not clear |
| Peter J Nestor, Daniele Altomare, Cristina Festari, Alexander Drzezga, Jasmine Rivolta, Zuzana Walker, Femke Bouwman, Stefania Orini, Ian Law, Federica Agosta, Javier Arbizu, Marina Boccardi, Flavio Nobili, Giovanni Battista Frison. Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia. European journal of nuclear medicine and molecular imaging. vol 45. issue 9. 2018-12-12. PMID:29736698. |
to assess the clinical utility of fdg-pet as a diagnostic aid for differentiating alzheimer's disease (ad; both typical and atypical forms), dementia with lewy bodies (dlb), frontotemporal lobar degeneration (ftld), vascular dementia (vad) and non-degenerative pseudodementia. |
2018-12-12 |
2023-08-13 |
Not clear |
| Changyoun Kim, Brian Spencer, Edward Rockenstein, Hodaka Yamakado, Michael Mante, Anthony Adame, Jerel Adam Fields, Deborah Masliah, Michiyo Iba, He-Jin Lee, Robert A Rissman, Seung-Jae Lee, Eliezer Maslia. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Molecular neurodegeneration. vol 13. issue 1. 2018-12-12. PMID:30092810. |
synucleinopathies of the aging population are an heterogeneous group of neurological disorders that includes parkinson's disease (pd) and dementia with lewy bodies (dlb) and are characterized by the progressive accumulation of α-synuclein in neuronal and glial cells. |
2018-12-12 |
2023-08-13 |
Not clear |
| Julia Schumacher, Luis R Peraza, Michael Firbank, Alan J Thomas, Marcus Kaiser, Peter Gallagher, John T O'Brien, Andrew M Blamire, John-Paul Taylo. Functional connectivity in dementia with Lewy bodies: A within- and between-network analysis. Human brain mapping. vol 39. issue 3. 2018-12-11. PMID:29193464. |
dementia with lewy bodies (dlb) is a common form of dementia and is characterized by cognitive fluctuations, visual hallucinations, and parkinsonism. |
2018-12-11 |
2023-08-13 |
Not clear |
| Patrick M Flanigan, Mitra A Khosravi, James B Leverenz, Babak Tous. Color Vision Impairment Differentiates Alzheimer Dementia From Dementia With Lewy Bodies. Journal of geriatric psychiatry and neurology. vol 31. issue 2. 2018-12-11. PMID:29658429. |
dementia with lewy bodies (dlb) is frequently misdiagnosed for alzheimer dementia (ad), especially in its earlier stages. |
2018-12-11 |
2023-08-13 |
Not clear |
| Giovanni Palermo, Roberto Ceravolo, Ubaldo Bonuccell. Advances in the pharmacotherapeutic management of dementia with Lewy bodies. Expert opinion on pharmacotherapy. vol 19. issue 15. 2018-12-11. PMID:30212224. |
dementia with lewy bodies (dlb) is the second most common type of dementia in people over 65 years of age. |
2018-12-11 |
2023-08-13 |
Not clear |
| Masateru Matsushita, Yusuke Yatabe, Asuka Koyama, Akiko Katsuya, Daisuke Ijichi, Yusuke Miyagawa, Hiroto Ikezaki, Noboru Furukawa, Manabu Ikeda, Mamoru Hashimot. Are saving appearance responses typical communication patterns in Alzheimer's disease? PloS one. vol 13. issue 5. 2018-11-27. PMID:29791460. |
in this study, we investigated whether sars are typical communication patterns in people with alzheimer's disease (ad), compared with mild cognitive impairment (mci) or dementia with lewy bodies (dlb). |
2018-11-27 |
2023-08-13 |
Not clear |
| Anastasia Bougea, Leonidas Stefanis, George P Paraskevas, Evangelia Emmanouilidou, Efthimia Efthymiopoulou, Kostas Vekrelis, Elisabeth Kapak. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease. Journal of neurology. vol 265. issue 10. 2018-11-26. PMID:30083953. |
given the overlapping of neuropathological, neurochemical and neuropsychiatric profiles of parkinson's disease dementia (pdd), dementia with lewy bodies (dlb) and alzheimer's disease (ad), their differential diagnosis is challenging. |
2018-11-26 |
2023-08-13 |
Not clear |
| Manraj Bhamra, Anto P Rajkumar, Dominic H Ffytche, Chris Kalafati. Successful management of persistent distressing neuropsychiatric symptoms by clozapine in a patient suffering from dementia with Lewy bodies. BMJ case reports. vol 2018. 2018-11-13. PMID:30054321. |
dementia with lewy bodies (dlb) is the second most common neurodegenerative dementia associated with poor prognosis and high carers' burden. |
2018-11-13 |
2023-08-13 |
Not clear |
| Seung Pil Yun, Donghoon Kim, Sangjune Kim, SangMin Kim, Senthilkumar S Karuppagounder, Seung-Hwan Kwon, Saebom Lee, Tae-In Kam, Suhyun Lee, Sangwoo Ham, Jae Hong Park, Valina L Dawson, Ted M Dawson, Yunjong Lee, Han Seok K. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Molecular neurodegeneration. vol 13. issue 1. 2018-11-09. PMID:29310663. |
mutations in glucocerebrosidase (gba) cause gaucher disease (gd) and increase the risk of developing parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2018-11-09 |
2023-08-13 |
Not clear |
| Olivier Bousiges, Frédéric Blan. Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body. Geriatrie et psychologie neuropsychiatrie du vieillissement. vol 16. issue 2. 2018-11-07. PMID:29877185. |
dementia with lewy body (dlb) is the second most common form of dementia after alzheimer's disease (ad), accounting for 15% to 20% of neuropathologically defined cases. |
2018-11-07 |
2023-08-13 |
Not clear |
| Chih-Kuang Cheng, Yu-Chien Tsao, Yuan-Chih Su, Fung-Chang Sung, Hsu-Chih Tai, Woon-Man Kun. Metabolic Risk Factors of Alzheimer's Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study. Behavioural neurology. vol 2018. 2018-10-30. PMID:29971140. |
alzheimer's disease (ad) and dementia with lewy bodies (dlb) share many risk factors. |
2018-10-30 |
2023-08-13 |
Not clear |